In the BioHarmony Drug Report Database
Megace, Megace Es (megestrol acetate) is a small molecule pharmaceutical. Megestrol acetate was first approved as Megace on 1982-01-01. It is used to treat anorexia, breast neoplasms, cachexia, and endometrial neoplasms in the USA. Megestrol acetate’s patent is valid until 2024-04-22 (FDA).
Image (chem structure or protein)